Chemours Co
NYSE:CC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its 3-Year Average (13.1), the stock would be worth $14.76 (36% downside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 20.6 | $23.18 |
0%
|
| 3-Year Average | 13.1 | $14.76 |
-36%
|
| 5-Year Average | 9.3 | $10.5 |
-55%
|
| Industry Average | 11 | $12.36 |
-47%
|
| Country Average | 14.4 | $16.14 |
-30%
|
Forward EV/EBITDA
Today’s price vs future ebitda
| Today's Enterprise Value | EBITDA | Forward EV/EBITDA | ||
|---|---|---|---|---|
|
$6.1B
|
/ |
Jan 2026
$335m
|
= |
|
|
$6.1B
|
/ |
Dec 2026
$870.2m
|
= |
|
|
$6.1B
|
/ |
Dec 2027
$1B
|
= |
|
|
$6.1B
|
/ |
Dec 2028
$1.1B
|
= |
|
Forward EV/EBITDA shows whether today’s EV/EBITDA still looks high or low once future ebitda are taken into account.
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
Chemours Co
NYSE:CC
|
3.5B USD | 20.6 | -9 | |
| ZA |
S
|
Sasol Ltd
JSE:SOL
|
137.2B ZAR | 5.6 | 57 | |
| DE |
|
Basf Se
XETRA:BAS
|
46.7B EUR | 9.3 | 28.8 | |
| CN |
|
Ningxia Baofeng Energy Group Co Ltd
SSE:600989
|
206.5B CNY | 16.2 | 18.2 | |
| JP |
R
|
Resonac Holdings Corp
XMUN:SWD
|
11.9B EUR | 16.2 | 75.7 | |
| ZA |
O
|
Omnia Holdings Ltd
JSE:OMN
|
14.6B ZAR | 7.5 | 12.3 | |
| IN |
|
Pidilite Industries Ltd
NSE:PIDILITIND
|
1.4T INR | 42 | 61.5 | |
| JP |
|
Showa Denko KK
TSE:4004
|
2.3T JPY | 16.6 | 77.7 | |
| JP |
M
|
Mitsubishi Chemical Group Corp
F:M3C0
|
7.4B EUR | 5.8 | 14.8 | |
| JP |
|
Mitsubishi Chemical Holdings Corp
TSE:4188
|
1.3T JPY | 5.8 | 14.8 | |
| IN |
|
SRF Ltd
NSE:SRF
|
742.2B INR | 21.9 | 41.3 |
Market Distribution
| Min | 0 |
| 30th Percentile | 10 |
| Median | 14.4 |
| 70th Percentile | 21.5 |
| Max | 1 767 274.1 |
Other Multiples
Chemours Co
Glance View
In the ever-evolving landscape of chemical manufacturing, Chemours Co. stands out as a testament to adaptation and innovation. Spun off from DuPont in 2015, Chemours made its mark by inheriting a robust portfolio that included titanium technologies, fluoroproducts, and chemical solutions. With titanium dioxide as a cornerstone of its operations, the company supplies essential pigments that imbue products like coatings and plastics with their vibrant colors and brightness. However, it’s the fluoroproducts segment that tells the more dynamic side of Chemours' story. The division is responsible for producing Teflon and other fluoropolymers, which find their way into countless applications from automotive to electronics. These products not only define durability and non-stick conveniences in daily life but also drive a significant portion of the company's revenue. Despite the legacy grounding Chemours in proven cash flows, it's the company’s pivot towards sustainability and eco-innovation that paints a compelling portrait of its future. Launching its Opteon line of refrigerants, designed to minimize environmental impact, underscores Chemours’ commitment to leading with green solutions amid a backdrop of global climate concerns. Further pushing the envelope with its “Chemours Future of Chemistry” initiative, the company aims to leverage its scientific prowess to develop products that are not only profitable but sustainable. Operating in this dual role of a traditional powerhouse and a forward-looking innovator, Chemours navigates the complexities of modern chemical demands by aligning profitability with a responsible outlook.
